TRANSDERMALE ARZNEIMITTELZUBEREITUNGEN MIT WIRKSTOFFKOMBINATIONEN ZUR BEHANDLUNG DER PARKINSON-KRANKHEIT

摘要

The transdermal pharmaceutical preparations for the treatment of Parkinson's disease contain a combination of at least two active substances selected from the following groups of active substances: dopamine agonists and L-dopa, monoamine oxidase inhibitors, anticholinergics, NMDA-receptor antagonists, sympathomimetics; at least two of the said active substances being members of different active substance groups.